Opening If Clinical Immunologists Can't Be Chemists, Should They Be Population Biologists?
If Clinical Immunologists Can't Be Chemists, Should They Be Population Biologists?
- Length
- 1 h 2 min
- Level
- Graduate
- Recorded
- University of Washington2022
Chapter 1 of 10: Before the lecture
Wener proposes calibrating antinuclear antibody assays to healthy-population percentiles and Z-scores.
Clinical antibody assays for autoimmune and infectious disease mostly lack the metrological traceability and international units that clinical chemistry relies on. Wener, speaking at University of Washington Laboratory Medicine Grand Rounds, proposes harmonizing them by population distributions instead. He starts with immunofluorescence antinuclear antibody testing on HEp-2 cells and draws on proficiency survey data showing titer variability across laboratories and commercial kits. The 1:80 titer entry criterion for lupus classification shows why consistent cutoffs matter. He then converts results to Z-scores against healthy controls and extends the approach to SARS-CoV-2 antibody levels as probabilistic markers of protection.
Clinical antibody assays for autoimmune and infectious disease mostly lack the metrological traceability and international units that clinical chemistry relies on. Wener, speaking at University of Washington Laboratory Medicine Grand Rounds, proposes harmonizing them by population distributions instead. He starts with immunofluorescence antinuclear antibody testing on HEp-2 cells and draws on proficiency survey data showing titer variability across laboratories and commercial kits. The 1:80 titer entry criterion for lupus classification shows why consistent cutoffs matter. He then converts results to Z-scores against healthy controls and extends the approach to SARS-CoV-2 antibody levels as probabilistic markers of protection.
Recommendations of the American College of Rheumatology (ACR) Antinuclear Antibody (ANA) Task Force
Review in Clinical Chemistry (December)
Pisetsky et al. Ann Rheum Dis 2018;77:911-913
Long-Term Variability in Immunofluorescence Titer of Antibodies to Nuclear Antigens Observed in Clinical Laboratory Proficiency Survey
Fink S, et al.
Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Accuracy

This lecture
Talk 5 of 14 of Laboratory Medicine Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
ANA International Recommendations 2014
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Metrological Traceability and its Implementation
Autoimmun Highlights
ISO 17511:2020
Frontiers in Immunology
Report of U.S. Collaborative Study on Alpha-fetoprotein in Relation to Neural-Tube Defects
Anti-Nuclear Antibody Quantitation: Calibration and Harmonization Adjustment via Population Interrogation
Antibody Binding vs Vaccine Efficacy, Vaccine & Variant
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
WHO anti-SARS-CoV-2 Ig Standard 2020
Evaluation of Commercial Anti-SARS-CoV-2 Antibody Assays and Comparison of Standardized Titers in Vaccinated Health Care Workers
Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays
Diagnostics 2021, 11, 1496
Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity
Bradley B, et al. J Clin Microbiol, 2021 Aug 18(9):e0189821
Thakar A, et al. Seroconversion rates following COVID-19 vaccination among patients with cancer. Cancer Cell. 2021 Aug 9(9): 1081-1090.